So I think what we’re about with these trials is very much looking at those patients who have bulky thoracic disease. It’s difficult to control even with the best of systemic treatments and it is likely that when they relapse that’s where they’ll relapse. So the hope is that by giving radiotherapy early, you’re preventing or delaying relapse, you’re improving quality of life and improving patient outcomes...
So I think what we’re about with these trials is very much looking at those patients who have bulky thoracic disease. It’s difficult to control even with the best of systemic treatments and it is likely that when they relapse that’s where they’ll relapse. So the hope is that by giving radiotherapy early, you’re preventing or delaying relapse, you’re improving quality of life and improving patient outcomes. To do that, obviously, we’re using now up-to-date radiotherapy techniques. So conformal therapy for certain tumors. We’re looking at high-dose fractionations and using whatever radiotherapy technology centers have available for them. And a similar thing in quartz lung should be quiet lung or more likely quart or more accurately quart is not correct it should be quiet: those were using low-dose radiotherapy treatments or palliative radiotherapy to try and just, say, sort of keep symptoms at bay.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.